Electra Therapeutics IPO Expected to Price Above Midpoint

3-line summary

• Electra Therapeutics' IPO is expected to price above the midpoint of its range, according to Investing.com.
• This follows the company's earlier filing for an IPO to fund immune disease drugs.

This summary is our own processing of the source article; see the source link below for full context.